Natural Antimicrobial Products from Plants and Fungi: Current Knowledge and Future Prospects, 2nd Edition

Dear Colleagues,

Plants and fungi are rich sources of thousands of secondary metabolites, which consist of low-molecular weight compounds, e.g., terpenoids and steroids, fatty-acid-derived substances and polyketides, alkaloids, nonribosomal polypeptides, and shikimate-derived. These compounds exhibit different bioactivities, such as antibacterial, antifungal, and antiviral, with different mechanisms for killing pathogens.

The increased emergence of antimicrobial-resistant pathogens is a major healthcare problem worldwide. It is estimated that antimicrobial resistance contributes annually to approximately 700,000 deaths across the world.

Plants and fungi offer exceptional chemical diversity with a wide variety of biological activities and thus are the most promising sources for drug discovery and development.

The aim of this Special Issue is to present the status of and future trends in natural products from plants and fungi with antimicrobial properties (i.e., antibacterial, antifungal, antiviral). Other suitable topics are methods for increase in metabolite yield (e.g., bioelicitation) and investigation of genetic bases in metabolite production. Alternative use of plants and fungal compounds and extracts with antimicrobial activities in food, beverage, supplements, and cosmetic may also be part of this Special Issue.

The Special Issue may include research papers and reviews on the antimicrobial properties of extracts and/or new metabolites from plants and fungi, a dynamic field at the intersection of microbiology, biotechnology, pharmacology, and biology.

Dr. Paola Angelini
Prof. Dr. Luigi Menghini
Prof. Roberto Venanzoni
Prof. Dr. Giustino Orlando
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.